Citius Pharmaceuticals, Inc.CTXRNASDAQ
Loading
Debt to Assets Over TimeFair Value
Percentile Rank57
3Y CAGR+32.5%
5Y CAGR-14.8%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+32.5%/yr
vs +1.7%/yr prior
5Y CAGR
-14.8%/yr
Recent acceleration
Acceleration
+30.9pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthFair Value
PeriodValueYoY Change
20250.01+514.5%
20240.00-51.5%
20230.00-21.9%
20220.01-0.9%
20210.01-80.6%
20200.03+417.6%
20190.01+7.1%
20180.01-21.4%
20170.01-76.9%
20160.03-